Janet Woodcock

Janet Woodcock (born August 29, 1948) is an American physician who is currently serving as the acting Commissioner of the U.S. Food and Drug Administration (FDA).[2] She joined the FDA in 1986, and has held a number of senior leadership positions there including terms as the Director of Center for Drug Evaluation and Research (CDER) from 1994 to 2004 and 2007–2021.[3]... On January 27, 2021 a coalition of 28 public health groups and opioid organizations sent a letter to the Biden Administration regarding Woodcock's position as Acting Commissioner of the FDA. The letter said in part that "as the Director of the FDA’s Center for Drug Evaluation and Research (CDER) for more than 25 years, Dr. Woodcock presided over one of the worst regulatory agency failures in U.S. history."[35] Examples of improper opioid decisions mentioned in the letter include "approving Opana without adequate evidence of safety or long-term efficacy, approving Zohydro despite a vote of 11-2 against approval by a scientific advisory committee, and approving promotion of OxyContin for children as young as 11 years old." https://en.wikipedia.org/wiki/Janet_Woodcock